This update applies to the following plan types: Medicaid and Long-Term Care. So if you are a provider that accepts any of these plans then this blog post is for you!
What is changing?
For any DOS on Jan 1, 2026 and thereafter Nebraska Medicaid (DOH) will discontinue the coverage and reimbursement of hyaluronan intraarticular injection fort the treatment of symptomatic knee osteoarthritis.
Why was this change made?
Due to lack of robust evidence demonstrating, the clinical relevance and therefore these injections are deemed not medically necessary. These injections will not be covered under both pharmacy and medical benefit.
Which codes are affected?
J7320, J7321, J7322, J7324, J7325, J7326, J7327, J7329, J7331, J7332. (image via cms website)

Find this type of information useful? Subscribe to my website for more payer related updates! #medicalbilling #medicalcoding, #reimbursement
- FidelisCare: pre- pay claim review for COB – third party payers
- Tobacco screening services- proper coding and billing- UPMC Community Behavioral Health Org:UPMC Community Behavioral Health Org
- Are you using the proper Anesthesia codes for fascial plane blocks?
- HighMark BCBS: reimbursement for massage therapy services
- NYS Medicaid: reduce denials MAT/ OASAS services-

Leave a comment